Skip to content

CalAmp CAMP Total Equity

Total Equity at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$491.41M+3.3%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$394.88M+12.8%
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$471.51M+65.0%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$58.13M-276%
Polaryx Therapeutics, Inc.
 logo
Polaryx Therapeutics, Inc. PLYX
$2.49M-41.5%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$211.94M+285%

Other financials

Income statement

See full
Revenue$1.3M+50.8%
Operating income-$13.1M+0.2%
Net income-$18.3M-47.4%
EPS (diluted)-$0.32+48.4%

Balance sheet

See full
Cash & equivalents$100.8M+97.9%
Total debt$2.1M-73.2%
Total assets$105.5M+68.0%

Cash flow

See full
Operating cash flow-$11.0M+23.1%
CapEx--100%
Free cash flow-$11.0M+24.6%

Valuation

See full
Market cap$226.92M+666%
Enterprise value$128.2M-3,860%
P/S57.7×+47.8×

Profitability

See full
Operating margin-1,335.2%-512pp
Net margin-2,193.7%-581pp
FCF margin-1,254%

Returns & leverage

See full
Return on equity-209.3%
Debt / equity0.1×-0.1×
Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CalAmp's total equity?
CalAmp (CAMP) reported total equity of $30.9M in Q1 2026.
How has CalAmp's total equity changed year-over-year?
CalAmp's total equity decreased by 40.1% year-over-year, from $51.57M to $30.9M.
What is the long-term trend for CalAmp's total equity?
Over 3 years (2022 to 2025), CalAmp's total equity has grown at a -14.9% compound annual growth rate (CAGR), from -$77.53M to $47.7M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.